Published in Cancer Weekly, March 13th, 2007
"We are extremely pleased to have Ms. Wiesinger, a seasoned pharmaceutical and biotech industry veteran, join our Board of Directors," stated Mark Ahn, Ph.D., President and Chief Executive Officer. "With more than 20 years of pharmaceutical operating experience, Ms Wiesinger's wealth of industry management, development and commercial expertise make her an excellent addition to Hana's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.